Drug Farm

Drug FarmDrug Farm
DF

Drug Farm

A biopharmaceutical company focused on drug discovery and development.

Website
ActiveShanghai, China
Rate
Advertise here

About

Drug Farm is a biopharmaceutical company that announced the successful first closing of its $55 million Series D financing. The company is involved in drug discovery and development, with operations in Shanghai and Albany, NY. The Series D round was co-led by Shanghai Pudong Leading Area Investment Center and Shanghai Puxing Collaborative Private Equity Fund Partnership Enterprise, with participation from new investors Tukar Capital, Fuzhou Xinhe Fund, Shenzhen Luohu Donghai Chempartner Investment Fund, and Keyuan Pharma, as well as existing investors like BioVeda China Fund (BVCF) and YD C.

Technology stack

detected 2026-07-13
Emailnone
Comments

No comments yet. Be the first to share your take.

Frequently asked

What does Drug Farm do?

Drug Farm is a biopharmaceutical company that announced the successful first closing of its $55 million Series D financing. The company is involved in drug discovery and development, with operations in Shanghai and Albany, NY. The Series D round was co-led by Shanghai Pudong Leading Area Investment Center and Shanghai Puxing Collaborative Private Equity Fund Partnership Enterprise, with participation from new investors Tukar Capital, Fuzhou Xinhe Fund, Shenzhen Luohu Donghai Chempartner Investme…

How much funding has Drug Farm raised?

Drug Farm has raised a total of $55M in funding. The most recent round on record is Series D.

Where is Drug Farm headquartered?

Drug Farm is headquartered in Shanghai, , China.

What industry does Drug Farm operate in?

Drug Farm operates in Biotechnology, Pharmaceuticals, Drug Discovery, Biotech, Clinical Trials, HealthTech.

What is Drug Farm's revenue?

StartupHub estimates Drug Farm's annual revenue at $6.6M (range $1.8M to $20.9M, 37% confidence), based on comparable companies in the sector.

What is Drug Farm's valuation?

StartupHub estimates Drug Farm's effective valuation at $215.6M (range $137.5M to $330.0M, 25% confidence), based on comparable companies in the sector.